PepGen Inc (PEPG)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PEPG
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(13.8) + peer(0.2*-3.3) + term(0.0) → 4.17% (capped ±15.0)
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Provisional scorecard: fewer than 4 guided quarters in the corpus.
Earnings prints and pre-announcements detected in the SEC filing stream.
of this Current Report on Form 8-K (this “Form 8-K”), including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such f…
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On May 12, 2026, PepGen Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2026 and other business updates and issued a press release titled “ PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights .” A copy of the press release is furnished as Exhibit 99.1. The information provided in this Current Report on Form 8-K (this “Form 8-K”), including Exhibit 99.1, shall not be deemed “file…
Results of Operations and Financial Condition. On March 4, 2026, PepGen Inc. (the "Company") announced its financial results for the year ended December 31, 2025 and issued a press release titled "PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights". A copy of the press release is furnished as Exhibit 99.1. The information provided in this Current Report on Form 8-K (this “Form 8-K”), including Exhibit 99.1, shall not be deemed “filed” for purpose…
of this Form 8-K shall be deemed to be furnished and not filed: Exhibit Number Description 99.1 Press release issued by PepGen Inc. on November 12, 2025 104 Cover Page Interactive Data File (embedded within Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN INC. Date: November 12, 2025 By: /s/ Noel Donnelly Noel Donnelly,…
of this Form 8-K shall be deemed to be furnished and not filed: Exhibit Number Description 99.1 Press release issued by PepGen Inc. on August 7, 2025 104 Cover Page Interactive Data File (embedded within Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN INC. Date: August 7, 2025 By: /s/ Noel Donnelly Noel Donnelly, Chief…
of this Form 8-K shall be deemed to be furnished and not filed: Exhibit Number Description 99.1 Press release issued by PepGen Inc. on May 8, 2025 104 Cover Page Interactive Data File (embedded within Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN INC. Date: May 8, 2025 By: /s/ Noel Donnelly Noel Donnelly, Chief Financ…
Results of Operations and Financial Condition. On February 24, 2025, PepGen Inc. (the "Company") announced its financial results for the year ended December 31, 2024 and issued a press release titled "PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights". A copy of the press release is furnished as Exhibit 99.1. The information provided in this Current Report on Form 8-K (this “Form 8-K”), including Exhibit 99.1, shall not be deemed “filed” for pur…
of this Form 8-K shall be deemed to be furnished and not filed: Exhibit Number Description 99.1 Press release issued by PepGen Inc. on November 7, 2024 104 Cover Page Interactive Data File (embedded within Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN, INC. Date: November 7, 2024 By: /s/ Noel Donnelly Noel Donnelly, C…
of this Form 8-K shall be deemed to be furnished and not filed: Exhibit Number Description 99.1 Press release issued by PepGen Inc. on August 8, 2024 104 Cover Page Interactive Data File (embedded within Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN, INC. Date: August 8, 2024 By: /s/ Noel Donnelly Noel Donnelly, Chief…
of this Form 8-K shall be deemed to be furnished and not filed: Exhibit Number Description 99.1 Press release issued by PepGen Inc. on May 14, 2024 104 Cover Page Interactive Data File (embedded within Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN, INC. Date: May 14, 2024 By: /s/ Noel Donnelly Noel Donnelly, Chief Fin…
of this Form 8-K shall be deemed to be furnished and not filed: Exhibit Number Description 99.1 Press release issued by PepGen Inc. on March 6, 2024 104 Cover Page Interactive Data File (embedded within Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN INC. Date: March 6, 2024 By: /s/ Noel Donnelly Noel Donnelly, Chief Fi…